Skip to content

Testing the effect of Kumkumadi face cream enriched with Shankha Bhasma in people with Acne

A Pharmaceutical and Clinical Study of Kumkumadi Face Cream Enriched with Shankha Bhasma in Mukhadushika with Special Reference to Acne Vulgaris - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097621
Enrollment
60
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

Government PG Ayurvedic College and Hospital, Chaukaghat, Varanasi, 221001
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study includes patients aged 15-35 years having pidika as a classical symptom of Mukhadushika irrespective of gender, caste and socioeconomic status. Mild to moderate cases with no recent use of any acne medications (Antibiotics, Creams, Steroids, Hormonal therapy) are chosen for the research to avoid confounding effects.

Exclusion criteria

Exclusion criteria: Patients with Pidika appearing on parts of the body other than face, as well as those with other skin conditions such as Kshudraroga and Kustharoga, or acne caused by side effects of previously applied drugs, were not included in the study. Individuals with comedonal acne or excessively oily skin and patients below 15 years and above 35 years of age were also excluded.

Design outcomes

Primary

MeasureTime frame
Improvement in AcneTimepoint: 15th day, 30th day. 2 follow up at an interval of 15 days after completion of trial at 45th day and 60th day

Secondary

MeasureTime frame
Complete relief from AcneTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Manish Mishra

Government PG Ayurvedic College and Hospital, Chaukaghat, Varanasi Uttar Pradesh, 221001

drankitg01@gmail.com9532016160

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026